Home/Filings/4/0001209191-22-043143
4//SEC Filing

Wolchko J Scott 4

Accession 0001209191-22-043143

CIK 0001434316other

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 6:18 PM ET

Size

19.8 KB

Accession

0001209191-22-043143

Insider Transaction Report

Form 4
Period: 2022-07-21
Wolchko J Scott
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2022-07-21$2.70/sh+30,000$81,000461,546 total
  • Sale

    Common Stock

    2022-07-21$33.07/sh19,171$633,985431,546 total
  • Sale

    Common Stock

    2022-07-21$32.54/sh10,829$352,376450,717 total
  • Exercise/Conversion

    Common Stock

    2022-07-22$2.70/sh+6,246$16,864437,792 total
  • Sale

    Common Stock

    2022-07-22$33.28/sh620$20,634431,546 total
  • Sale

    Common Stock

    2022-07-22$31.33/sh2,923$91,578434,869 total
  • Sale

    Common Stock

    2022-07-22$32.61/sh2,703$88,145432,166 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-07-2130,0006,246 total
    Exercise: $2.70Exp: 2027-01-03Common Stock (30,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-07-226,2460 total
    Exercise: $2.70Exp: 2027-01-03Common Stock (6,246 underlying)
Footnotes (7)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020.
  • [F2]Represents the weighted average sale price of the shares sold ranging from $31.82 to $32.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6.
  • [F3]Represents the weighted average sale price of the shares sold ranging from $32.83 to $33.33 per share.
  • [F4]Represents the weighted average sale price of the shares sold ranging from $30.99 to $31.74 per share.
  • [F5]Represents the weighted average sale price of the shares sold ranging from $32.02 to $33.01 per share.
  • [F6]Represents the weighted average sale price of the shares sold ranging from $33.03 to $33.67 per share.
  • [F7]This option is fully vested.

Issuer

FATE THERAPEUTICS INC

CIK 0001434316

Entity typeother

Related Parties

1
  • filerCIK 0001586893

Filing Metadata

Form type
4
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 6:18 PM ET
Size
19.8 KB